Real-world therapeutic benefits of patients on insulin glargine versus NPH insulin

Metformin: an Old Therapy that Deserves a New Indication for the Treatment of Obesity

(2016) L. I. Igel et al.   Current Atherosclerosis Reports

Lower limbs edema by insulin glargine treatment: two other cases in pediatrics

(2015) Dario Iafusco et al.   ACTA DIABETOLOGICA

Bilateral lower limbs edema with “wooden” character induced by insulin glargine treatment

(2015) Elena Succurro et al.   ACTA DIABETOLOGICA

Systematic review and meta-analysis of randomized clinical trials comparing efficacy and safety outcomes of insulin glargine with NPH insulin, premixed insulin preparations or with insulin detemir in type 2 diabetes mellitus

(2015) Przemyslaw Rys et al.   ACTA DIABETOLOGICA

Identification of predictors of response to basal insulin and DPP4 inhibitors in patients with type 2 diabetes failing to other therapies

(2015) Matteo Monami et al.   ACTA DIABETOLOGICA

Successful desensitization in patient with type 2 diabetes with an insulin allergy using insulin pump and glargine

(2014) G. Petrovski et al.   ACTA DIABETOLOGICA

Insulin Therapy in People With Type 2 Diabetes: Opportunities and Challenges?

(2014) Philip Home et al.   DIABETES CARE

More satisfied, but why? A pooled patient-level analysis of treatment satisfaction following the initiation of insulin glargine vs. comparators in insulin-naïve patients with type 2 diabetes mellitus

(2013) W. Polonsky et al.   DIABETES OBESITY & METABOLISM

Comparison of Safety and Efficacy of Insulin Glargine and Neutral Protamine Hagedorn Insulin in Older Adults with Type 2 Diabetes Mellitus: Results from a Pooled Analysis

(2012) Pearl Lee et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy of Insulin Analogs in Achieving the Hemoglobin A1c Target of

(2011) D. Giugliano et al.   DIABETES CARE

Increase of body weight during the first year of intensive insulin treatment in type 2 diabetes: systematic review and meta-analysis

(2011) A. E. Pontiroli et al.   DIABETES OBESITY & METABOLISM

The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern

(2011) C. J. Currie et al.   DIABETES OBESITY & METABOLISM

Medical Antihyperglycaemic Treatment of Type 2 Diabetes Mellitus

(2009) S. Matthaei et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes

(2008) Mike A. Baxter   ACTA DIABETOLOGICA

Nocturnal Glucose Metabolism after Bedtime Injection of Insulin Glargine or Neutral Protamine Hagedorn Insulin in Patients with Type 2 Diabetes

(2008) Thomas Linn et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM